Teach me more Sensei. SNSESensei Biotherapeutics has hit bottom and is now turning around for a what may eventuate to be an impulse. Momentum is growing, fractally sound picture, no doubt volume spikes can be seen.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−21.34 EUR
−29.13 M EUR
0.00 EUR
827.41 K
About Sensei Biotherapeutics, Inc.
Sector
Industry
CEO
John K. Celebi
Website
Headquarters
Rockville
Founded
1999
FIGI
BBG00Z5H68M1
Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where 4070 is featured.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange SENSEI BIOTHERAPEUTICS INC stocks are traded under the ticker 4070.
We've gathered analysts' opinions on SENSEI BIOTHERAPEUTICS INC future price: according to them, 4070 price has a max estimate of 30.24 EUR and a min estimate of 25.92 EUR. Watch 4070 chart and read a more detailed SENSEI BIOTHERAPEUTICS INC stock forecast: see what analysts think of SENSEI BIOTHERAPEUTICS INC and suggest that you do with its stocks.
Yes, you can track SENSEI BIOTHERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
SENSEI BIOTHERAPEUTICS INC is going to release the next earnings report on Nov 11, 2025. Keep track of upcoming events with our Earnings Calendar.
4070 earnings for the last quarter are −3.32 EUR per share, whereas the estimation was −4.75 EUR resulting in a 30.18% surprise. The estimated earnings for the next quarter are −3.20 EUR per share. See more details about SENSEI BIOTHERAPEUTICS INC earnings.
SENSEI BIOTHERAPEUTICS INC revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
4070 net income for the last quarter is −6.34 M EUR, while the quarter before that showed −7.51 M EUR of net income which accounts for 15.47% change. Track more SENSEI BIOTHERAPEUTICS INC financial stats to get the full picture.
No, 4070 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 7, 2025, the company has 15 employees. See our rating of the largest employees — is SENSEI BIOTHERAPEUTICS INC on this list?
Like other stocks, 4070 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SENSEI BIOTHERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.